Skip Navigation LinksHome > November 2014 - Volume 36 - Issue 8 > Bone Scintigraphy in Osteosarcoma: A Single Institution Exp...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0000000000000182
Online Articles: Clinical and Laboratory Observations

Bone Scintigraphy in Osteosarcoma: A Single Institution Experience

Powers, Jacquelyn M. MD*,†; Cost, Carrye MD‡,§; Cederberg, Kevin MD†,∥; Leonard, David PhD*,†; Leavey, Patrick J. MD, MB, BCh, BAO, LRCP&SI, MRCPI, DCH*,†

Collapse Box


Bone scintigraphy is a well-established method to evaluate for metastatic disease in osteosarcoma. We identified a patient who had a negative (cold) bone scan at skeletal relapse and consequently reviewed the frequency of cold scans in osteosarcoma at our institution. No cold scans were identified at diagnosis, and only 1 patient had a cold scan at skeletal recurrence. No correlation was identified between clinical outcomes and bone scan features, other than identification of metastatic disease. Patients with skeletal recurrence were all symptomatic, thus we suggest that bone scintigraphy is not indicated in routine postchemotherapy surveillance for patients with osteosarcoma.

© 2014 by Lippincott Williams & Wilkins.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.